TREATMENT OF PERIOCULAR CAPILLARY HEMANGIOMA WITH TOPICAL CLOBETASOL PROPIONATE

Citation
Oa. Cruz et al., TREATMENT OF PERIOCULAR CAPILLARY HEMANGIOMA WITH TOPICAL CLOBETASOL PROPIONATE, Ophthalmology, 102(12), 1995, pp. 2012-2015
Citations number
22
Categorie Soggetti
Ophthalmology
Journal title
ISSN journal
01616420
Volume
102
Issue
12
Year of publication
1995
Pages
2012 - 2015
Database
ISI
SICI code
0161-6420(1995)102:12<2012:TOPCHW>2.0.ZU;2-I
Abstract
Background: Hemangiomas pose a therapeutic challenge because they can threaten vision in infancy and early childhood. Intralesional injectio n of corticosteroid is widely regarded as the treatment of choice for hemangiomas which induce strabismus or significant refractive error, o r occlude the visual axis. Ocular and systemic complications such as e yelid necrosis, central retinal artery occlusion, and adrenal suppress ion have been reported rarely after corticosteroid injection. Methods: Three infants were treated with clobetasol propionate (Temovate) crea m for vision-threatening eyelid hemangiomas. Results: Treatment with t his topical fluorinated corticosteroid produced a measurable reduction in the size of the hemangiomas, which permitted clearing of the visua l axis. No regional side effects were noted. in addition, the patients did not demonstrate evidence of hypothalamic-pituitary-adrenal axis s uppression. Conclusions: This treatment modality appears to provide an additional alternative for managing superficial periocular hemangioma s which threaten vision.